LDLR and atherosclerosis: In line with these data, bempedoic acid, an ACLY inhibitor that is used to reduce cholesterol synthesis and treat dyslipidaemia, was shown to attenuate atherosclerosis in ApoE−/− mice and LDLr−/− mice [157].